PGNYProgyny, Inc.

$1B

Q4 2025 Earnings

Healthcare Medical - Healthcare Information Services

Income Statement

Revenue

$318M+6.7% YoY

Gross Profit

$77M24.1% margin

Operating Income

$15M4.8% margin

Net Income

$12M3.9% margin

EPS (Diluted)

$0.14

QoQ Revenue Growth

+1.6%

Cash Flow

Operating Cash Flow

$54M

Free Cash Flow

$49M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$742M

Total Liabilities

$226M

Stockholders' Equity

$516M

Cash & Equivalents

$112M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$318M	$298M	+6.7%
Gross Profit	$77M	$63M	+21.2%
Operating Income	$15M	$16M	-3.6%
Net Income	$12M	$11M	+18.5%

Revenue Segments

Fertility benefit services revenue

$209M66%

Pharmacy benefit services revenue

$110M34%

PGNY Q4 2025 Earnings — Progyny, Inc. Revenue & Financial Results | Market Cap Arena